Synergistic Anti-Tumor Effect of Pegylated Recombinant Human Hyaluronidase (PEGrHuPH20) with Cytotoxic Agents following Intravenous Administration in a Hormone Refractory Prostate Cancer Xenograft Model (PDF)
Pharmacokinetics and Glucodynamics of an Insulin Analog and Regular Insulin Injected with Recombinant Human Hyaluronidase: Fast-Acting Insulins Made Faster (PDF)
Intravenous Administration of Recombinant Human Hyaluronidase (rHuPH20) Modulates Tumor Interstitial Fluid Pressure and Pericellular Hyaluronan in a Human Prostate Carcinoma Xenograft Model (PDF)
PEGPH20: PEGylated Human Recombinant PH20 Hyaluronidase Shows Significant Antitumor Activity Concomitant with Hyaluronan Reduction in the PC3 Hormone Refractory Prostate Cancer Model (PDF)
Accelerated Insulin Pharmacokinetics and Improved Glycemic Control in T1DM Patients by Coadministration of Prandial Insulin with Recombinant Human Hyaluronidase (PDF)
Accelerated Insulin Pharmacokinetics and Improved Glycemic Control in T1DM Patients by Coadministration of Prandial Insulin with Recombinant Human Hyaluronidase - Part 2 EASD 2009 (PDF)
Accelerated Insulin Pharmacokinetics and Improved Glycemic Control in T2DM Patients by Coinjection of Prandial Insulin with Hyaluronidase - ADA 2010 (PDF)
Close This Window
